Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 3
2023 2
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nahn s (399 results)?
Serum anti-NMDA receptor antibodies are linked to memory impairment 12 months after stroke.
Arlt FA, Sperber PS, von Rennenberg R, Gebert P, Teegen B, Georgakis MK, Fang R, Dewenter A, Görtler M, Petzold GC, Wunderlich S, Zerr I, Dichgans M, Prüss H, Endres M; DEMDAS Investigators. Arlt FA, et al. Mol Psychiatry. 2025 Apr;30(4):1359-1368. doi: 10.1038/s41380-024-02744-w. Epub 2024 Oct 30. Mol Psychiatry. 2025. PMID: 39478168 Free PMC article.
Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer's disease.
Herden JM, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, Nuhn S, Volpers C, Schlung A, Goebel S, Kück F, Villar-Piqué A, Schmidt C, Wedekind D, Zerr I. Herden JM, et al. Among authors: nuhn s. Alzheimers Res Ther. 2023 Jun 8;15(1):106. doi: 10.1186/s13195-023-01249-y. Alzheimers Res Ther. 2023. PMID: 37291640 Free PMC article.
Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer's disease.
Herden JM, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, Nuhn S, Volpers C, Schlung A, Goebel S, Kück F, Villar-Piqué A, Schmidt C, Wedekind D, Zerr I. Herden JM, et al. Among authors: nuhn s. Alzheimers Res Ther. 2023 Jun 22;15(1):116. doi: 10.1186/s13195-023-01263-0. Alzheimers Res Ther. 2023. PMID: 37349779 Free PMC article. No abstract available.
Risk factors for dementia and cognitive impairment within 5 years after stroke: a prospective multicentre cohort study.
Filler J, Georgakis MK, Janowitz D, Duering M, Fang R, Dewenter A, Bode FJ, Stoesser S, Kindler C, Hermann P, Nolte CH, Liman TG, Kerti L, Bernkopf K, Ikenberg B, Glanz W, Wagner M, Spottke A, Waegemann K, Goertler M, Wunderlich S, Endres M, Zerr I, Petzold GC, Dichgans M; DEMDAS Investigators. Filler J, et al. Lancet Reg Health Eur. 2025 Aug 19;56:101428. doi: 10.1016/j.lanepe.2025.101428. eCollection 2025 Sep. Lancet Reg Health Eur. 2025. PMID: 40893447 Free PMC article.
Minor neuropsychological deficits in patients with subjective cognitive decline.
Wolfsgruber S, Kleineidam L, Guski J, Polcher A, Frommann I, Roeske S, Spruth EJ, Franke C, Priller J, Kilimann I, Teipel S, Buerger K, Janowitz D, Laske C, Buchmann M, Peters O, Menne F, Fuentes Casan M, Wiltfang J, Bartels C, Düzel E, Metzger C, Glanz W, Thelen M, Spottke A, Ramirez A, Kofler B, Fließbach K, Schneider A, Heneka MT, Brosseron F, Meiberth D, Jessen F, Wagner M; DELCODE Study Group. Wolfsgruber S, et al. Neurology. 2020 Sep 1;95(9):e1134-e1143. doi: 10.1212/WNL.0000000000010142. Epub 2020 Jul 7. Neurology. 2020. PMID: 32636322
Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease.
Billette OV, Ziegler G, Aruci M, Schütze H, Kizilirmak JM, Richter A, Altenstein S, Bartels C, Brosseron F, Cardenas-Blanco A, Dahmen P, Dechent P, Dobisch L, Fliessbach K, Freiesleben SD, Glanz W, Göerß D, Haynes JD, Heneka MT, Kilimann I, Kimmich O, Kleineidam L, Laske C, Lohse A, Rostamzadeh A, Metzger C, Munk MH, Peters O, Preis L, Priller J, Scheffler K, Schneider A, Spottke A, Spruth EJ, Ramirez A, Röske S, Roy N, Teipel S, Wagner M, Wiltfang J, Wolfsgruber S, Yakupov R, Zeidman P, Jessen F, Schott BH, Düzel E, Maass A; DELCODE Study Group. Billette OV, et al. Neurology. 2022 Aug 23;99(8):e775-e788. doi: 10.1212/WNL.0000000000200667. Epub 2022 Jun 3. Neurology. 2022. PMID: 35995589 Free PMC article.
Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age.
Ballarini T, Melo van Lent D, Brunner J, Schröder A, Wolfsgruber S, Altenstein S, Brosseron F, Buerger K, Dechent P, Dobisch L, Duzel E, Ertl-Wagner B, Fliessbach K, Freiesleben SD, Frommann I, Glanz W, Hauser D, Haynes JD, Heneka MT, Janowitz D, Kilimann I, Laske C, Maier F, Metzger CD, Munk M, Perneczky R, Peters O, Priller J, Ramirez A, Rauchmann B, Roy N, Scheffler K, Schneider A, Spottke A, Spruth EJ, Teipel SJ, Vukovich R, Wiltfang J, Jessen F, Wagner M; DELCODE study group. Ballarini T, et al. Neurology. 2021 Jun 15;96(24):e2920-e2932. doi: 10.1212/WNL.0000000000012067. Neurology. 2021. PMID: 33952652 Free PMC article.
High-Sensitivity Cardiac Troponin T and Cognitive Function Over 12 Months After Stroke-Results of the DEMDAS Study.
von Rennenberg R, Nolte CH, Liman TG, Hellwig S, Riegler C, Scheitz JF, Georgakis MK, Fang R, Bode FJ, Petzold GC, Hermann P, Zerr I, Goertler M, Bernkopf K, Wunderlich S, Dichgans M, Endres M; DEMDAS investigators *. von Rennenberg R, et al. J Am Heart Assoc. 2024 Mar 19;13(6):e033439. doi: 10.1161/JAHA.123.033439. Epub 2024 Mar 8. J Am Heart Assoc. 2024. PMID: 38456438 Free PMC article.